Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer

被引：0
|
作者：
Kenji Hashimoto
Atsuo Takashima
Kengo Nagashima
Shun-suke Okazaki
Takako Eguchi Nakajima
Ken Kato
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
机构：
[1] National Cancer Center Hospital,Gastrointestinal Oncology Division
[2] Josai University,Faculty of Pharmaceutical Sciences
来源：
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷
关键词：
Advanced gastric cancer; Second-line chemotherapy; Prognostic factor; Time to progression; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1059 / 1064
页数：5
相关论文
共 50 条
  • [1] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Hashimoto, Kenji
    Takashima, Atsuo
    Nagashima, Kengo
    Okazaki, Shun-suke
    Nakajima, Takako Eguchi
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (07) : 1059 - 1064
  • [2] Importance of Progression-free Survival in Second-line Chemotherapy in Patients With Advanced or Recurrent Gastric Cancer
    Sano, Akihiko
    Sohda, Makoto
    Hosoi, Nobuhiro
    Tateno, Kohei
    Watanabe, Takayoshi
    Uchida, Shintaro
    Nakazawa, Nobuhiro
    Osone, Katsuya
    Okada, Takuhisa
    Shiraishi, Takuya
    Sakai, Makoto
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    [J]. ANTICANCER RESEARCH, 2023, 43 (11) : 5205 - 5213
  • [3] PROGRESSION-FREE SURVIVAL AND POSTPROGRESSION SURVIVAL IN PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH FIRST-LINE CHEMOTHERAPY
    Shitara, K.
    Matsuo, K.
    Muro, K.
    Ohtsu, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 232 - 232
  • [4] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Shitara, Kohei
    Matsuo, Keitaro
    Muro, Kei
    Doi, Toshihiko
    Ohtsu, Atsushi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
  • [5] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [6] CORRELATION BETWEEN THE EFFECTS OF FIRST-LINE CHEMOTHERAPY AND SURVIVAL TIME FROM SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Tabuse, H.
    Yasui, H.
    Funakoshi, T.
    Hamauchi, S.
    Tsushima, T.
    Taniguchi, H.
    Todaka, A.
    Yokota, T.
    Machida, N.
    Yamasaki, K.
    Fukutomi, A.
    Onozawa, Y.
    Boku, N.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 99 - 99
  • [7] Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer
    Herrmann, Christina
    Abel, Ulrich
    Stremmel, Wolfgang
    Jaeger, Dirk
    Herrmann, Thomas
    [J]. ONCOLOGY, 2007, 73 (5-6) : 335 - 339
  • [8] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
  • [9] Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapy
    Klempner, Samuel J.
    Bhangoo, Munveer S.
    Luu, Hubert Y.
    Kim, Seung Tae
    Chao, Joseph
    Kim, Kyoung-Mee
    Lee, Jeeyun
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 1198 - +
  • [10] Second-line chemotherapy for patients with advanced gastric cancer
    Daisuke Takahari
    [J]. Gastric Cancer, 2017, 20 : 395 - 406
12345